DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Bicine is an investigational drug.
There have been 37 clinical trials for Bicine. The most recent clinical trial was a Phase 3 trial, which was initiated on June 30th 2007.
The most common disease conditions in clinical trials are Breast Neoplasms, Leukemia, and Leukemia, Myeloid, Acute. The leading clinical trial sponsors are Gruppo Italiano Malattie EMatologiche dell'Adulto, Hellenic Oncology Research Group, and University of Cologne.
Recent Clinical Trials for Bicine
|A Study to Evaluate the Combination of ATX-101 and Platinum-based Chemotherapy||Novotech (Australia) Pty Limited||Phase 1/Phase 2|
|A Study to Evaluate the Combination of ATX-101 and Platinum-based Chemotherapy||THERAPIM PTY LTD||Phase 1/Phase 2|
|Study of DAC Combined With HAAG Regimen in Newly Diagnosed Younger AML Patients||Changzhou No.2 People's Hospital||Phase 3|